Delivery Order SPE2DB20D3101-SPE2DB21FK1H0
- Not listed
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,554.45. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA) on a firm fixed-price basis. The $23,008.30 delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- This federal contract award is for the delivery of SHINGRIX vial kits, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $10,690.10 with a completion date of January 26, 2023. This is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,813.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 19, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of SHINGRIX vaccine kits to support military healthcare programs. The $3,567.77 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.42, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 8, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $10,099.02, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition...
- This federal contract award is for the supply of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $10,642.68 and a completion date of April 11, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,862.92 and an Ultimate Completion Date of November 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award, valued at $5,345.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SHINGRIX vial kits. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FK1H0Delivery Order
This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,531.94, is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts demonstrate Amerisourcebergen Drug Corp's and Cencora, Inc.'s critical role in supplying essential pharmaceutical and medical products to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/4/21 |